Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Highnoon Laboratories Limited

Market Cap 51B 183M 159M 146M 137M 257M 17.46B 261M 1.72B 673M 8.49B 688M 674M 29.43B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 51B 183M 159M 146M 137M 257M 17.46B 261M 1.72B 673M 8.49B 688M 674M 29.43B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.49x
Free-Float
50.02%
Yield 2026 *
4.67%
Yield 2027 * 5.4%
1 day-0.04%
1 week-1.63%
Current month-0.75%
1 month+0.42%
3 months+7.18%
6 months-6.12%
Current year-5.86%
1 week 960
Extreme 960
983.48
1 month 929.5
Extreme 929.5
1,000.25
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 322.1
Extreme 322.1
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.04%-1.63%-0.42%+156.12% 183M
-2.41%+0.14%+39.53%+154.43% 1,010B
+1.07%+3.48%+53.75%+50.64% 580B
+1.32%+0.22%+18.35%+65.35% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.50%+8.37% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
+0.32%+1.61%+19.48%+63.42% 192B
Average +0.09%+0.82%+19.80%+51.58% 356.72B
Weighted average by Cap. -0.33%+1.00%+29.84%+66.17%

Financials

2026 *2027 *
Net sales 30.4B 109M 94.48M 87.12M 81.53M 153M 10.41B 155M 1.03B 401M 5.06B 410M 402M 17.54B 34.16B 123M 106M 97.91M 91.63M 172M 11.7B 175M 1.15B 451M 5.69B 461M 451M 19.71B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
12/06/26 962.59 -0.04% 63,602
11/06/26 962.97 -0.20% 11,805
10/06/26 964.92 -0.42% 20,500
09/06/26 968.98 +0.00% 11,887
08/06/26 968.97 -0.97% 13,009
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
962.59PKR
Average target price
1,121.00PKR
Spread / Average Target
+16.46%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!